These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. Post RM; Weiss SR CNS Neurosci Ther; 2011 Dec; 17(6):649-60. PubMed ID: 21159150 [TBL] [Abstract][Full Text] [Related]
3. Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview. Baldessarini RJ; Tondo L Clin Drug Investig; 1998; 15(4):337-51. PubMed ID: 18370489 [TBL] [Abstract][Full Text] [Related]
4. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. Post RM; Ketter TA; Uhde T; Ballenger JC CNS Drugs; 2007; 21(1):47-71. PubMed ID: 17190529 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians. Leo RJ; Narendran R Prim Care Companion J Clin Psychiatry; 1999 Jun; 1(3):74-84. PubMed ID: 15014689 [TBL] [Abstract][Full Text] [Related]
6. An interaction between carbamazepine and fluvoxamine. Martinelli V; Bocchetta A; Palmas AM; Del Zompo M Br J Clin Pharmacol; 1993 Dec; 36(6):615-6. PubMed ID: 12959283 [No Abstract] [Full Text] [Related]
7. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Post RM; Weiss SR Mol Neurobiol; 1996 Aug; 13(1):33-60. PubMed ID: 8892335 [TBL] [Abstract][Full Text] [Related]
8. Long term treatment of bipolar disorder. Silverstone T; Romans S Drugs; 1996 Mar; 51(3):367-82. PubMed ID: 8882376 [TBL] [Abstract][Full Text] [Related]
9. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
10. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up. Post RM; Leverich GS; Rosoff AS; Altshuler LL J Clin Psychopharmacol; 1990 Oct; 10(5):318-27. PubMed ID: 2124216 [TBL] [Abstract][Full Text] [Related]
11. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. Simhandl C; Denk E; Thau K J Affect Disord; 1993 Aug; 28(4):221-31. PubMed ID: 8227758 [TBL] [Abstract][Full Text] [Related]
12. Carbamazepine in the prophylaxis of mood disorders. Stuppaeck C; Barnas C; Miller C; Schwitzer J; Fleischhacker WW J Clin Psychopharmacol; 1990 Feb; 10(1):39-42. PubMed ID: 2307735 [TBL] [Abstract][Full Text] [Related]